REG-BARCLAYS PLC Form 8.3 - Willis Towers Watson plc - Amendment
08/01/2021 09:40
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210108:nBw7MjCnRa&default-theme=true
Form 8.3 - Willis Towers Watson plc - Amendment
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 05 January 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,992,177 2.32% 681,891 0.53%
(2) Derivatives (other than options):
354,221 0.27% 744,551 0.58%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,346,398 2.60% 1,426,442 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 203.0000 USD
Purchase 6 205.4650 USD
Purchase 40 202.5200 USD
Purchase 63 202.1204 USD
Purchase 100 203.7500 USD
Purchase 100 201.7600 USD
Purchase 102 201.6345 USD
Purchase 200 201.7250 USD
Purchase 212 201.9148 USD
Purchase 300 202.3566 USD
Purchase 323 202.1671 USD
Purchase 330 202.0087 USD
Purchase 372 201.9307 USD
Purchase 451 201.4862 USD
Purchase 502 202.6316 USD
Purchase 553 202.6831 USD
Purchase 748 202.6405 USD
Purchase 775 202.4187 USD
Purchase 844 202.5691 USD
Purchase 876 202.0768 USD
Purchase 1,058 202.5868 USD
Purchase 1,068 202.0973 USD
Purchase 1,106 204.1922 USD
Purchase 1,240 202.3632 USD
Purchase 1,390 201.7375 USD
Purchase 4,014 202.2455 USD
Purchase 4,146 202.3905 USD
Purchase 5,385 202.3278 USD
Purchase 6,542 201.9946 USD
Purchase 8,186 202.0000 USD
Purchase 8,778 202.3806 USD
Purchase 10,776 202.0185 USD
Purchase 12,442 202.4628 USD
Purchase 17,064 202.4400 USD
Purchase 18,979 202.1423 USD
Purchase 22,992 202.6602 USD
Purchase 27,162 202.1148 USD
Sale 6 201.7700 USD
Sale 9 202.6900 USD
Sale 38 203.5400 USD
Sale 100 204.2000 USD
Sale 100 204.6200 USD
Sale 100 204.0350 USD
Sale 115 202.7869 USD
Sale 200 203.8950 USD
Sale 209 202.6746 USD
Sale 248 201.9307 USD
Sale 287 202.4334 USD
Sale 336 202.0704 USD
Sale 723 202.8030 USD
Sale 737 203.3047 USD
Sale 768 202.9215 USD
Sale 860 202.0962 USD
Sale 1,026 202.0292 USD
Sale 1,096 202.6382 USD
Sale 1,208 202.8795 USD
Sale 1,400 202.6807 USD
Sale 1,400 202.9085 USD
Sale 1,716 202.1780 USD
Sale 1,771 202.5724 USD
Sale 1,849 202.7410 USD
Sale 2,016 202.9160 USD
Sale 2,700 203.0627 USD
Sale 2,736 202.8012 USD
Sale 4,182 202.2237 USD
Sale 5,104 202.0000 USD
Sale 6,194 201.9790 USD
Sale 7,324 202.2516 USD
Sale 10,441 202.5441 USD
Sale 10,502 202.2872 USD
Sale 20,905 202.0810 USD
Sale 31,035 202.0188 USD
Sale 40,477 202.4063 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 8 Jan 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210108005162/en/
(https://www.businesswire.com/news/home/20210108005162/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Entain PLC Barclays PLC - TR1: Notification of Major Holdings
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement